Stempoint Capital’s Ventyx Biosciences VTYX Stock Holding History

Stempoint Capital’s Portfolio VTYX Stock Details VTYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-167,470	Closed	-$521K	–	114
2025 Q3	$521K	Buy	+167,470	New	+$444K	0.1%	75

Other funds holding VTYX

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Stempoint Capital's VTYX Position: Q4 2025 in Review

Stempoint Capital sold out of Ventyx Biosciences (VTYX) in Q4 2025, closing a stake of 167,470 shares — an estimated $521K sold.

Stempoint Capital first reported a position in VTYX in Q3 2025 and held it in 1 quarter. The position peaked at $521K in Q3 2025. 139 funds tracked by Wall St. Rank hold VTYX as of Q4 2025.

Stempoint Capital reported no remaining Ventyx Biosciences position as of Q4 2025 after selling out during the quarter.
Stempoint Capital sold 167,470 Ventyx Biosciences shares in Q4 2025, an estimated $521K.
Stempoint Capital first reported a position in Ventyx Biosciences in Q3 2025 and held it in 1 quarter.
Stempoint Capital's Ventyx Biosciences position peaked at $521K in Q3 2025.
139 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2025.

Based on Stempoint Capital's 13F filing for Q4 2025, filed 17 Feb 2026.